Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bioterrorism
Paper Reveals New Way to Combat Bioterror Agents
September 9th, 2008
Dr. Scott Dessain, Associate Professor at the Lankenau Institute for Medical Research (LIMR) and Sharad P. Adekar, MD, Scientist at LIMR, are authors on a paper published in PLoS One, an international, peer-reviewed, open access, online publication by the Public Library of Science. This manuscript entitled: Neutralization of botulinum neurotoxin by a human monoclonal antibody specific for the catalytic light chain, examines antibodies that may be a valuable component for an antidote for individuals exposed to Botulinum neurotoxins (BoNTs). BoNTs are a family of toxins that cause the disease botulism, but they can also be used as bioterror agents that cause paralysis...
Source: Cancer Weekly (2008-09-09)
|
